GSK Lamictal's New Warning On Aseptic Meningitis May Help Pfizer's Lyrica
This article was originally published in The Pink Sheet Daily
Executive Summary
On-patent antiepileptics may have another arrow in their promotional quivers after the now-generic lamotrigine gets a label update with reports of 40 cases of aseptic meningitis.
You may also be interested in...
Historical Controls For Epilepsy Studies To Be Considered By Advisory Cmte.
GlaxoSmithKline's Lamictal XR and several drugs in the pipeline could see their quest for monotherapy indications affected by what the Peripheral and Central Nervous System Drugs Advisory Committee decides.
Historical Controls For Epilepsy Studies To Be Considered By Advisory Cmte.
GlaxoSmithKline's Lamictal XR and several drugs in the pipeline could see their quest for monotherapy indications affected by what the Peripheral and Central Nervous System Drugs Advisory Committee decides.
FDA Opts For MedGuide, Not Black Box For Anti-Epileptic Suicidality
FDA has made a decision on how to communicate the suicidality risk for anti-epileptic drugs: with the first novel approvals in that class since an advisory committee on the topic, FDA has opted for a Medication Guide over a "black box" warning
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: